Groundbreaking Cannabinoid-based Medicines
Innovative medicines targeting unmet needs, backed by real-world data.
Next-generation MDMA Analogue Program
Developing innovative treatments for severe psychological conditions
MDMA analogues have unique biochemical properties that make them attractive small molecules to develop into registered treatments for severe psychological conditions such as Post-Traumatic Stress Disorder.
UWA’s library is therefore a highly valuable drug discovery resource.
Research & Data Programs
Robust and ethically-sourced real-world patient data and technology-driven research programs
Emyria is also leading numerous innovative grant and award-winning research programs with global partners involving remote monitoring technology and psychedelic-assisted therapy.